HyperScale Bio

Join Our Community: Meet the geeks at the intersection of biology and technology. Learn how new AI models are being applied to everything from enzyme engineering to drug delivery. How will AI and machine learning increase our ability to make biology easier to engineer? How do AI models benchmark against each other? How will we produce enough data to feed into the models?

Featured Content and Speakers: Join the hottest AI and Bio startups, scale-ups, and biotech companies who will be showcasing their AI capabilities, including Atomic AI, Isomorphic Labs, Dyno Therapeutics, OpenAI, Arzeda, and Ginkgo Bioworks. Join Microsoft CTO Kevin Scott for a fireside chat with Stanford Professor Drew Endy on the future of AI and BIO. Meet the top partners from the biopharma industry, including Roche, Eli Lilly, Kim Branson (GSK), and Cynthia Hong (Novartis). Join thought leaders and investors such as Steve Jurvetson (Future Ventures), Peter Diamandis (XPrize Foundation), and Bryan Johnson (Don’t Die). Mix in the top tech bio investors from Flagship Pioneering, SOSV (Indie Bio), and Khosla Ventures, as well as leadership and funders from government AI funding agencies like ARPA-H and DARPA, and you have a SynBioBeta that should not be missed!